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Inﬂammatory mediators are thought to be involved in the systemic and local immune
response induced by the Tityus serrulatus scorpion envenomation. New functional aspects
of lipid mediators have recently been described. Here, we examine the unreported role of
lipid mediators in cell recruitment to the peritoneal cavity after an injection with Ts2 or
Ts6 toxins isolated from the T. serrulatus scorpion venom. In this report, we demonstrate
that following a single intraperitoneal (i.p.) injection of Ts2 or Ts6 (250 mg/kg) in mice,
there was an induction of leukocytosis with a predominance of neutrophils observed at 4,
24, 48 and 96 h. Moreover, total protein, leukotriene (LT)B4, prostaglandin (PG)E2 and pro-
inﬂammatory cytokine levels were increased. We also observed an increase of regulatory
cytokines, including interleukin (IL)-10, after the Ts2 injection. Finally, we observed that
Ts2 or Ts6 injection in 5-lipoxygenase (LO) deﬁcient mice and in wild type (WT) 129sv
mice pre-treated with LTs and PGs inhibitors (MK-886 and celecoxib, respectively)
a reduction the inﬂux of leukocytes occurs in comparison to WT. The recruitment of these
cells demonstrated a phenotype characteristic of neutrophils, macrophages, CD4 and CD8
lymphocytes expressing GR1þ, F4/80þ, CD3þ/CD4þ and CD3þ/CD8þ, respectively. In
conclusion, our data demonstrate that Ts2 and Ts6 induce inﬂammation by mechanisms
dependent on lipid mediators and cytokine production. Ts2 may play a regulatory role
whereas Ts6 exhibits pro-inﬂammatory activity exclusively.
© 2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Envenomation in humans is a serious public health
problem that afﬂicts urban and rural areas throughout the





ier OA license.accidents caused by venomous or poisonous animals, 53%
of envenomation cases and 14 deaths (0.203% lethality)
were caused by scorpions (Ministério da Saúde, 2011).
Tityus serrulatus venom (TsV) consists of a complex
mixture of mucus, low molar mass components and
neurotoxic proteins (Müller, 1993; Gwee et al., 2002;
revised by Cologna et al., 2009). It is well known that T.
serrulatus neurotoxins speciﬁcally interact with Naþ, Kþ,
Cl, and Caþ2 ion channels (Becerril et al., 1997). Ts2, also
known as TsTX-III (Possani et al., 1991), is a neurotoxin that
acts on Naþ channels (Cestèle and Catterall, 2000; Denac
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the Universal Protein Resource Knowledgebase (www.
uniprot.org) or the Worldwide Protein Data Bank (www.
pdb.org). Ts2 (Uniprot ID P68410) contains 62 amino
acids, including 8 cysteine residues (Mansuelle et al., 1992).
The peptide has a theoretical molar mass of 6998.0 Da and
a pI of 7.70 (http://web.expasy.org/protparam/). Ts2 is
a sodium channel inhibitor a-neurotoxin that inhibits the
rapid inactivation of NaV1.2, NaV1.3, NaV1.5, NaV1.6 and
NaV1.7, but does not affect NaV1.4, NaV1.8 or DmNaV1
(Cologna et al., 2012). The overall structure of the Ts2model
consists of three b-strands and one a-helix that are
arranged in a triangular shape forming a cysteine-
stabilized a-helix ⁄ b-sheet (CSab) motif (Cologna et al.,
2012). While Ts6, also called TsTX-IV (Arantes et al.,
1989), acts on Kþ channels (Coronas et al., 2003). Ts6
(Uniprot ID P59936) contains 40 amino acids, including 8
cysteine residues (Pimenta et al., 2003). The theoretical
molar mass and pI of the peptide are 4514.2 Da and 8.50,
respectively (http://web.expasy.org/protparam/). Ts6 is
a potassium channel toxin alpha-KTx 12.1 that inhibits high
conductance calcium-activated potassium channels
(Novello et al., 1999) and weakly inhibits Shaker B potas-
sium channels (Coronas et al., 2003). The structure of the
peptide consists of an alpha-helix connected to a triple-
stranded beta-sheet stabilized by four disulﬁde bonds
(Oyama et al., 2005). Our group has previously demon-
strated that following stimulation with Ts1, Ts2 or Ts6, the
in vitro release of inﬂammatory mediators by peritoneal
macrophages (J774.1) is independent of the action of these
toxins on ion channels (Zoccal et al., 2011).
Several reports demonstrated that cytokines are
increased after envenomation. Magalhães et al. (1999)
observed an increase of interleukins (IL)-1a, IL-6, Inter-
feron (IFN)-g and granulocyte-macrophage colony-stimu-
lating factor (GM-CSF) in the serum of patients who were
stung by T. serrulatus. Furthermore, the increased levels of
GM-CSF in severe envenomation might be involved in
neutrophilia induced by T. serrulatus venom (Magalhães
et al., 1999). The synthesis of anti-inﬂammatory cyto-
kines, such as IL-10, was also observed in the plasma of
patients with both moderate and severe cases of enveno-
mation (Fukuhara et al., 2003; Petricevich, 2010). Scorpion
venoms can stimulate the immune-neuroendocrine axis by
inducing the release of catecholamines, corticosteroids,
bradykinin (Chaudry et al., 1989; Sofer et al., 1996;
Magalhães et al., 1999; Pessini et al., 2003) and eicosanoids
mediators, such as prostaglandin (PG)E2, lipoxin A2 (LXA2)
and leukotriene (LT)B4 (Nascimento et al., 2005; Teixeira
et al., 1997).
Eicosanoids, derived from the enzymatic oxygenation of
arachidonic acid (AA), are signaling molecules that control
key cellular processes, including cell activation, metabo-
lism, migration, cell proliferation and death (Funk, 2001;
Yaqoob, 2003). PGE2 and LTB4 are AA-derived metabolites
from pathways dependent on cyclooxygenase (COX) and 5-
lipoxygenase (5-LO), respectively (Peters-Golden and
Brock, 2000; Samuelson, 2000; Funk, 2001). These lipid
mediators are involved in inﬂammation and several
homeostatic biological functions, including vascular
permeability and leukocyte inﬂux to the bronchoalveolarﬂuid (Teixeira et al., 1997; Nascimento et al., 2005). PGE2 is
involved in the inﬂammatory response, and in the
neutrophil recruitment (Fruscella et al., 2001) in mice
inoculated with T. serrulatus scorpion venom (Pessini et al.,
2006). PGE2 is also produced after i.p. inoculation of
phospholipase A2 from the Bothrops asper snake venom in
mice (Moreira et al., 2011). Additionally, the action of cro-
toxin (neurotoxin isolated from Crotalus durissus terriﬁcus
venom) is modulated by 5-LO-derived lipidic mediators in
rats (Nogueira-Neto et al., 2008). However, there is a lack
of knowledge regarding the participation of these lipid
mediators in cell recruitment to the peritoneal cavity
induced by T. serrulatus Ts2 or Ts6.
To address this question, we ﬁrst demonstrated the
kinetics of cell recruitment to the peritoneal cavity of mice
injected with Ts2 or Ts6 isolated from the venom of scor-
pion T. serrulatus, and characterized the possible inﬂam-
matory mediators involved in cell migration. Second, we
inhibited PGs and LTs synthesis by treatment with cele-
coxib, a COX-2 inhibitor, or MK-886, a 5-LO activation
protein (FLAP) inhibitor, and characterized the cell types
and cell recruitment kinetics to the peritoneal cavity of
mice injected with Ts2 or Ts6.
2. Materials and methods
2.1. Toxins
Toxins Ts2 and Ts6, representing 3% and 2.5% of the total
crude soluble TsV, respectively, were puriﬁed and stored at
20 C as previously described (Arantes et al., 1989;
Cologna et al., 2011, 2012). Prior to the experiments, Ts2
and Ts6 were dissolved in phosphate buffered saline (PBS)
and ﬁltered through sterilizing membranes (Spritzenﬁlter:
0.22 mm, TPP, Switzerland). To determine whether the
puriﬁed toxins were contaminated by the endotoxin LPS,
a Limulus Amoebocyte Lysate test (LAL) was performed
according to the manufacturer’s instructions (QCL-1000,
Bio Whittaker, Cambrex Company, Walkersville, MD, USA).
2.2. Animals
Male 129sv mice (6–8 weeks old) were obtained from
the animal facility of Faculdade de Ciências Farmacêuticas
de Ribeirão Preto (FCFRP) – Universidade de São Paulo
(USP). Male 5-LO deﬁcient (5 LO/) mice were obtained
from The Jackson Laboratory (Bar Harbor, ME, USA) and
raised at FCFRP-USPwith their age-matchedmalewild type
littermates (WT-background, strain 129). These mice were
maintained under standard laboratory conditions. All
experiments were approved and conducted in accordance
with the guidelines of the University Animal Care
Committee (process n0 09.1.847.53.4).
2.3. Evaluation of leukocyte inﬂux into the peritoneal cavity
Groups of six mice were injected i.p. with 300 mL of Ts2
or Ts6 (250 mg/kg) diluted in sterile PBS. The experiments
were performed twice (n ¼ 12). The controls received
300 mL of sterile PBS. After 4, 24, 48 and 96 h, the animals
were euthanatized in a CO2
 chamber and 3 mL of PBS was
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massaged for 1 min. Peritoneal ﬂuid was collected using
a syringe with a needle inserted into the inguinal region.
Total peritoneal cells were counted in Turk’s solution using
Neubauer chambers. Differential peritoneal leukocyte
counts were performed on cytospin preparations stained
with commercial kit based on the Romanowsky staining
procedure (Panótico Laborclin, Paraná, Brazil). After
centrifugation (400  g, for 10 min, at 10 C), the cell-free
peritoneal ﬂuid was stored at 80 C.
2.4. Injection of Ts2 or Ts6 in mice and treatment with
celecoxib or MK-886
Groups of six mice (129sv and 5-LO/) were injected
i.p. with 300 mL of Ts2 or Ts6 (250 mg/kg) diluted in PBS.
Control animals received 300 mL of sterile PBS. The exper-
iments were performed twice (n ¼ 12). One group of 129sv
was orally treated with celecoxib or MK-886 (5 mg/kg/
0.5 mL) 1 day as well as 1 h prior to the i.p. injection with
Ts2 or Ts6, and again every 24 h until the end of the
experiment. After 4 and 96 h of i.p. injection, the animals
were euthanized in a CO2
 chamber, and the peritoneal
ﬂuid was collected as described above.
2.5. Quantiﬁcation protein
Total proteins were quantiﬁed in the cell-free peritoneal
ﬂuid from 129sv mice injected with Ts2 or Ts6 by Coo-
massie protein assay reagent (Rockford, USA), according to
the manufacturer’s instructions.
2.6. Cytokine measurements
The cell-free peritoneal ﬂuid obtained from 129sv mice
injected with Ts2 or Ts6 was used to measure TNF-a, IL-6,
IL-1b, IFN-g, IL-10 and IL-4 by ELISA using speciﬁc anti-
bodies (puriﬁed and biotinylated) and cytokine standards,
according to the manufacturers’ instructions (R & D
Systems, Minneapolis, USA). Optical densities were
measured at 405 nm in a microplate reader (mQuant, Biotek
Instruments Inc.). For each sample, cytokine levels were
obtained from a standard curve established with the
appropriate recombinant cytokine (results expressed in pg/
mg of total protein). Sensitivities were >10 pg/mL.
2.7. LTB4 and PGE2 measurements
LTB4 and PGE2 were quantiﬁed in the cell-free perito-
neal ﬂuid from 129sv mice injected with Ts2 or Ts6 by
enzyme immunoassay (Cayman Chemical, USA). Brieﬂy,
supernatant dilutions were incubated with conjugated
eicosanoid-acetylcholinesterase and antiserum in 96-well
plates precoated with anti-rabbit immunoglobulin G anti-
bodies. After incubation overnight at 4 C, plates were
washed and enzyme substrate (Ellman’s reagent) was
added for 60–120 min at 25 C. Sample absorbance was
determined at 420 nm in a microplate reader (mQuant,
Biotek Instruments Inc.), and concentrations of eicosanoids
were calculated based on the standard curve. The detection
limit was approximately 13 pg/mL.2.8. Immunophenotyping of the lavage peritoneal cells
CD3, CD4, CD8, F4/80 and GR1 expression in the cells
from the peritoneal ﬂuid recovered from 129sv mice
injected with Ts2 or Ts6, with or without celecoxib or MK-
886 treatment, was determined by ﬂow cytometry immu-
nostaining protocol using antibody conjugated with ﬂuo-
rochromes (BD Biosciences, NJ, USA). Speciﬁc murine IgG2a
isotype controls were used to monitor non-speciﬁc
binding. Stained peritoneal cells were washed with PBS
containing 2% fetal bovine serum (FBS), pelleted by
centrifugation at 400  g and ﬁxed with PBS containing 1%
(w/v) paraformaldehyde. A total of 30,000 events were
acquired (FACSCanto; Becton Dickinson, CA, USA) using
the FACS Diva software (version 6.1.3) for data acquisition
and analysis.
2.9. Statistical analyses
Data were expressed as the mean  SEM. Statistical
variations were analyzed using multi-factorial ANOVA.
P < 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Ts2 or Ts6 induces leukocyte inﬂux and increase total
protein into the peritoneal cavity
The response of mice to the i.p. injection of Ts2 or Ts6
was studied by evaluating the inﬂux of leukocytes into the
peritoneal cavity. Ts2 or Ts6 i.p. inoculation inmice induced
an increase of total leukocyte (Fig. 1A) and neutrophil
(Fig. 1B) numbers in the peritoneal cavity throughout the
experimental time course (4, 24, 48 and 96 h). The mono-
nuclear cells were increased after 4 and 96 h post Ts2
injection compared to mice inoculated with PBS. Ts6
increased mononuclear cells only after 96 h (Fig. 1C). We
also determined the acute phase protein levels in the
peritoneal ﬂuid of mice injected with Ts2 or Ts6 (Fig. 2).
Compared to control, the total protein levels of the peri-
toneal ﬂuid peaked between 24 and 48 h and then
decreased at 96 h after injection with Ts2 or Ts6 (Fig. 2).
Taken together, these results demonstrated that Ts2 or Ts6
induced an inﬂammatory response in the peritoneal cavity,
mainly during the ﬁrst 24 h.
3.2. Ts2 and Ts6 induce cytokine release
Fig. 3 shows the proﬁle of inﬂammatory cytokines
released in the peritoneal cavity after the injectionwith Ts2
or Ts6. We demonstrated that Ts2 and Ts6 altered the
release of speciﬁc cytokines in a time-dependent manner.
Ts2 augmented the release of IL-6, IFN-g and the regulatory
cytokine IL-10 at 4 h (Fig. 3A, D and E, respectively); at 24 h,
however, only IL-10was increased (Fig. 3E). At 48 h post Ts2
injection, there was an increase in the levels of TNF-a, IFN-
g, IL-10 and IL-4 (Fig. 3B, D, E and F, respectively), while at
96 h, we only observed an increase in TNF-a, IL-1b and IL-10
(Fig. 3B, C and E, respectively). Additionally, we observed
a mild difference in the cytokine proﬁle following the Ts6
injection compared to Ts2. After 4 h, Ts6 increased the
Fig. 1. Leukocyte, neutrophil and mononuclear cells recruitment induced by
i.p. Ts2 or Ts6 (250 mg/kg) injection in mice. Control groups were injected
with PBS. (A) Leukocyte, (B) neutrophils and (C) mononuclear cells were
numbered after 4, 24, 48 and 96 h of the injection. Data are expressed as the
mean  SEM from two independent experiments (n ¼ 12 mice per group).
*P < 0.05; **P < 0.001 and ***P < 0.0001 when compared to the control PBS
group.
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tively), while only the release of IFN-gwas increased at 24 h
(Fig. 3D). At 48 h, TNF-a and IFN-g levels were increased
(Fig. 3B and D), while only TNF-a was increased after 96 h
(Fig. 3B). For comparison, the changes in the corresponding
cytokine release were also measured in a control group of
mice that received PBS injection.Fig. 2. Effects of intraperitoneal Ts2 or Ts6 (250 mg/kg) injections on the
total protein levels in the peritoneal cavity. Control groups were injected
with PBS. The total protein was determined by the Coomassie protein assay
reagent after 4, 24, 48 and 96 h post injection. Data are expressed as the
mean  SEM from two independent experiments (n ¼ 12 mice per group).
*P < 0.05 when compared to PBS group.3.3. Ts2 or Ts6 induces the release of LTB4 and PGE2
To determine whether LTB4 and PGE2 are produced as
a result of the toxin injection, groups of mice were i.p.
inoculated with Ts2 or Ts6 and the peritoneal ﬂuid was
collected after 4, 24, 48 and 96 h. Compared to controls, we
observed a peak in the production of both lipid mediators
4 h and 24 h after the injection with Ts2 and Ts6, respec-
tively (Fig. 4). Additionally, a signiﬁcant increase in the LTB4
production was observed after 24 and 48 h of Ts2 injection,
followed by a decrease at 96 h, relative to control (Fig. 4A).
Ts6 induced an increase in LTB4 release throughout the
experimental time course (Fig. 4B). Moreover, PGE2 was
increased in Ts2 or Ts6-dependent manner at all time
points, compared to control (Fig. 4). The rate of
prostaglandin-leukotriene was maintained throughout the
course of the study.
3.4. Leukocyte recruitment induced by Ts2 or Ts6 is partially
dependent on the prostaglandin and leukotriene production
To understand the role that PGs and LTs play in cell
recruitment to the peritoneal cavity following Ts2 or Ts6,
we treated mice concomitantly with MK-886 (FLAP inhib-
itor) or celecoxib (COX-2 inhibitor). Treatment of 129sv
(WT) animals with MK-886 or celecoxib (5 mg/kg/day)
effectively reduced the number of leukocytes at 4 and 96 h
compared to the Ts2 injection, but only after 4 h compared
to the Ts6 injection (Fig. 5A); neutrophils were reduced at 4
and 96 h compared to the Ts2 or Ts6 injection (Fig. 5B);
mononuclear cells were reduced at 4 and 96 h compared to
Ts2, but only after 4 h compared to Ts6 (Fig. 5C). The same
pattern of leukocyte recruitment inhibition was observed
by treating the animals with MK-886 or celecoxib.
However, MK-886 was more efﬁcient than celecoxib in
inhibiting inﬂammatory cell recruitment in the presence of
Ts6 (Fig. 5).
We also compared the WT mice (129sv) with the 5-
LO/ mice following the Ts2 or Ts6 injection. Compared
to the WT mice that only received Ts2, we observed
inhibition of the total leukocytes, neutrophils and mono-
nuclear cells in 5-LO/ mice at 4 and 96 h after Ts2
injection (Fig. 5). Ts6 inhibited leukocytes and mono-
nuclear cells after 4 h, while neutrophils were inhibited
after 4 and 96 h compared to the WT mice that received
Ts6. The results demonstrated that the WT mice treated
with MK-886 displayed the same behavior as the 5-LO/
mice, suggesting that the Ts2 or Ts6-driven induction of
leukocyte recruitment, observed primarily in neutrophils,
is partially dependent on LTs.
3.5. Immunophenotypic characterization of cell recruitment
to the peritoneal cavity after Ts2 or Ts6 injection and MK-886
or celecoxib treatment
The peritoneal cell populations, obtained after Ts2 or
Ts6 injection and MK-886 or celecoxib treatment, were
characterized by ﬂow cytometry. We performed analyses
using anti-GR1, F4/80, CD3, CD4 and CD8 immunoglobu-
lins. The number of cells expressing GR1, a typical
neutrophil marker, changed signiﬁcantly between the
Fig. 3. Ts2 or Ts6 modulates levels of cytokines in the peritoneal cavity. (A) IL-6, (B) TNF-a, (C) IL-1b, (D) IFN-g, (E) IL-10 and (F) IL-4 were evaluated after 4, 24, 48
and 96 h following the Ts2 or Ts6 (250 mg/kg) injection. Control groups were injected with PBS. Data are expressed as the mean  SEM from two independent
experiments (n ¼ 12 mice per group). *P < 0.05 and **P < 0.001 compared to PBS group.
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groups. We observed an increase in GR1þ cells in the Ts2
or Ts6 only groups at 4 and 96 h. In the MK-886 or cele-
coxib treated groups, GR1þ cells decreased to the levels
similar to the PBS group at 4 h. At 96 h, the same proﬁle
was observed (Fig. 6A). The number of F4/80 positive cells
increased in the Ts2 or Ts6 group compared to PBS at 4 and
96 h, and decreased to Ts2þcelecoxib and Ts2þMK-886 at
4 h compared to Ts2 and to Ts6þMK-886 group at 96 h
compared to Ts6 (Fig. 6B). The same expression proﬁle was
observed in CD3þ/CD4þ and CD3þ/CD8 cells. Compared
to PBS, CD3þ/CD4þ and CD3þ/CD8þ expression increased
in Ts6 at 4 and 96 h and Ts2 at 96 h. CD3þ/CD4þ
expression decreased in Ts6þMK-886 at 4 h and Ts6þce-
lecoxib at 96 h compared to Ts6, while Ts2þMK-886 and
Ts2þcelecoxib demonstrated decreased expression at 96 h
compared to Ts2. CD3þ/CD8þ cell number decreasedfollowing the Ts6þcelecoxib and Ts6þMK-886 treatment
at 4 and 96 h compared to Ts6, and Ts2þcelecoxib and
Ts2þMK-886 treatment at 96 h compared to Ts2 (Fig. 6C
and D). These results suggest that the decreased expres-
sion of these markers can be related to the reduced
number of cells recruited into the peritoneal cavity as
observed in Figs. 1 and 5.
4. Discussion
Our study revealed two surprising and important new
ﬁndings. First, the kinetics of cell migration induced by the
active preparations permitted us to characterize a local
inﬂammatory reaction with the gradual increase in neutro-
phils, inﬂammatory cytokines (especially in the early phase
of response), and lipid mediators. Second, we demonstrated
that cell recruitment is partially dependent on PGs and LTs.
Fig. 4. Ts2 or Ts6 injection induces eicosanoid generation in the peritoneal
cavity. The PGE2 and LTB4 release was evaluated after 4, 24, 48 and 96 h
following the injection with (250 mg/kg) of Ts2 (A) or Ts6 (B). Control groups
were injected with PBS. Data are expressed as the mean  SEM from two
independent experiments (n ¼ 12 mice per group). *P < 0.001 compared to
PBS group relative to PGE2 and #P < 0.001 compared to PBS group relative to
LTB4.
K.F. Zoccal et al. / Toxicon 61 (2013) 1–106It is known that during the acute inﬂammatory
response, depending on the stimulus, the ﬁrst event is the
recruitment of neutrophils, followed by the arrival of
other cells, including macrophages and lymphocytes
(Medzhitov, 2008). A high leukocyte count in the victims
of scorpion envenomation is partially due to the action of
catecholamines, released by the scorpion’s venom and
known to induce leukocytosis through the mobilization of
marginated cells (Dàvila et al., 2002; Zeghal et al., 2000).
In this study, we demonstrated that the neutrophils were
the prominent cells of all cell types that migrated to the
peritoneal cavity. However, we also observed an increase
in the number of mononuclear cells in the later stages (at
96 h). The acute-phase response can also be characterized
by an increase in total protein levels between 24 and 48 h
(Fig. 2). Taken together, these results corroborate data in
the literature which indicate that the total protein
increase along with leukocytosis in the peritoneal cavity is
a characteristic of the local inﬂammatory response
(Petricevich, 2010).
Following the venom injection, a variety of cytokines
are released and the outcome of the inﬂammatory
response is dictated by a number of factors that include
the duration of the stimulus and the balance between pro
and anti-inﬂammatory responses (Petricevich, 2010).
Increased IL-6 and TNF-a levels were observed in plasma
from patients with different degrees of T. serrulatus
envenomation, as well as in human serum and mouse
macrophage supernatants (Magalhães et al., 1999;
Fukuhara et al., 2003; Pessini et al., 2003; Petricevich et al.,
2007). Our group demonstrated that TsV, Ts1 and Ts6 are
able to stimulate macrophages to produce IL-6 and TNF-
a in vitro (Zoccal et al., 2011). In the present study, weobserved a high increase of pro-inﬂammatory cytokines
(IL-6, TNF-a, IL-1b and IFN-g) in the early stage, especially
in response to Ts6. Moreover, it was previously demon-
strated that the regulatory cytokines IL-10 and IL-4 were
increased in serum of patients envenomed with T. serru-
latus scorpions and in experimental animals exposed to
Androctonus australis hector or Centruroides noxius
(Magalhães et al., 1999; Petricevich et al., 2007;
Petricevich, 2006; Adi-Bessalem et al., 2008). IL-10 func-
tions, in part, in key homeostatic mechanisms that control
the degree and duration of the inﬂammatory response
(Bazzoni et al., 2010). We observed an increase in the anti-
inﬂammatory cytokine release, including IL-10 and IL-4,
after Ts2 injection and primarily after 48 h. These results
corroborate our previous in vitro results (Zoccal et al.,
2011) and suggest that the venom may contain
compounds with divergent activities. Here, we observed
that Ts2 can induce the recruitment of neutrophils to the
site of interest (Fig. 1) and also stimulate the anti-
inﬂammatory cytokine (mainly IL-10) production in vivo
(Fig. 3). This result corroborate partially with our previous
ﬁndings which used in vitro stimulated peritoneal
macrophages and demonstrated that Ts2 had an anti-
inﬂammatory potential (Zoccal et al., 2011). However, it
is important to take into account that the expression and
production of pro or anti-inﬂammatory molecules by
a stimulus may vary depending on the microenvironment
used in the study (Bazzoni et al., 2010). Additionally,
behaviors in vivo and in vitro may differ due to numerous
factors, such as the presence of other resident cells, that
can interfere with the inﬂamed site. We speculated that
the neutrophils recruited by Ts2 to peritoneal cavity could
be the main source of IL-10, based on the fact that these
cells are present at the site of lung inﬂammation and
function as a source of IL-10 (Zhang et al., 2009). Thus, our
data suggest that Ts2 can play an important regulatory role
in vivo due to its ability to release anti-inﬂammatory
cytokines and recruit neutrophils to the peritoneal cavity.
During inﬂammation, lipid mediators such as PGs and
LTs can be released in addition to cytokines. These medi-
ators are induced after membrane disturbance that lead to
increased intracellular calcium (Lewis et al., 1990; Funk,
2001). In the present work, we demonstrated through
three different ﬁndings that the Ts2 or Ts6-induced
recruitment of cells to peritoneal cavity is partially
dependent on lipid mediators. First, we observed that Ts2
induced the production of PGE2 and LTB4. We suggest that
the resulting cell activation that culminates in the increase
of the downstream products of these pathways (LTs and
PGs), and possibly in the increased phospholipase A2
activity, a key enzyme involved in the formation of both
lipid mediators. Our results demonstrate a balance
between PGE2 and LTB4 and a corresponding increase of
both lipids that could be due to the action of cytokines
released at earlier time points. Unlike Ts2, Ts6 did not
induce LTB4 and PGE2 production during the initial cell
activation, but induced distinct amounts throughout the
activation time course. Ts6 induced an upregulation on
these mediators after 24 h and the rate of PGE2/LTB4
production remained constant throughout all the
previous time points (Fig. 4B). Taking into consideration
Fig. 5. Leukocyte, neutrophil and mononuclear cell recruitment increases in the peritoneal cavity after Ts2 or Ts6 injection by a mechanism partially dependent
on the lipid mediators. Pre-treatment with MK-886 (5 mg/kg/0.5 mL by gavage) or celecoxib (5 mg/kg/0.5 mL by gavage) signiﬁcantly reduced the number of cells
in the peritoneal cavity of 129sv mice. All treatments were performed 1 day and 1 h prior to Ts2 or Ts6 injection (250 mg/kg) and every 24 h until the end of the
experiment. Controls received only PBS. Data are expressed as the mean  SEM from two independent experiments (n ¼ 10 mice per group). *P < 0.001 compared
to PBS group and #P < 0.001 compared to 129sv mice group that received Ts2 or Ts6 injection. Leukocyte, neutrophil and mononuclear cell recruitment to the
peritoneal cavity of 5-LO/ (129-Alox5tm1Fun) mice is decreased compared to the strain-matched wild-type (WT) mice. Each strain was inoculated with Ts2 or
Ts6 (250 mg/kg) and allowed to recover for 4 and 96 h after stimulus. Data are expressed as the mean  SEM from two independent experiments (n ¼ 12 mice per
group). #P < 0.001 compared to 129sv mice group that received Ts2 or Ts6 injection.
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following the Ts2 or Ts6 injection, we investigated the role
of potent leukocyte chemoattractants known as LTs
(Faccioli et al., 1991; Herschman, 1996; Medeiros et al.,
1999). For this purpose, we pre-treated mice with MK-
886 to inhibit LTs synthesis (Ford-Hutchinson et al.,1980) and observed reduced cell numbers after Ts2 or
Ts6 injection. We also employed mice that were unable to
produce LTs (5-LO/) and injected them with Ts2 or Ts6.
These mice demonstrated decreased cell numbers
compared to WT animals. In addition, LTB4 was increased
in the peritoneal ﬂuid of mice exposed to Ts2 or Ts6 in
Fig. 6. Ts2 or Ts6 induced an increase of neutrophils, macrophages and lymphocytes in the peritoneal cavity. Cells were obtained frommice after the i.p. injection
with PBS, Ts2 or Ts6 with or without celecoxib or MK-886 pre-treatment as described in the Material and Methods section. The neutrophil, macrophage and
lymphocyte populations were analyzed for the percentage of classic markers for neutrophils, macrophages and T cells expressing an effector phenotype. (A) GR1þ
for neutrophils, (B) F4/80 for macrophage, (C) CD4þ T cells and (D) CD8þ T cells. Data are expressed as the mean  SEM from two independent experiments.
*P < 0.001 comparing PBS vs. Ts2 or Ts6; #P < 0.005 comparing Ts2 or Ts6 vs. celecoxib or MK-886.
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together, these results showed that LTs, predominantly
represented by LTB4, are necessary to promote cellular
migration following Ts2 or Ts6 inoculation.Taking into consideration that prostanoids are also
involved in cell recruitment, we explored the involvement
of cyclooxygenase (COX)-derived PGs in the cell increase
observed in our results. For that purpose, we pre-treated
K.F. Zoccal et al. / Toxicon 61 (2013) 1–10 9mice with a COX-2 inhibitor celecoxib (Warner et al.,
1999). Celecoxib-treated mice had a signiﬁcantly dimin-
ished cellular migration, indicating that PGs could be
involved in this process. Moreover, we also demonstrated
a signiﬁcant PGE2 increase in the peritoneal ﬂuid of mice
exposed to Ts2 or Ts6 compared with the PBS control. It is
known that the secretion of lipid mediators can be asso-
ciated with an inﬂux of neutrophils and an increase in
inﬂammatory cytokines (Medeiros et al., 1999; Fernandes
et al., 2007; Bagga et al., 2003). Taken together, these
results demonstrated that the inﬂux of cells to the peri-
toneal cavity induced by Ts2 or Ts6 is partially dependent
on LTs and PGs.
Finally, we immunophenotyped the cells recruited to
the peritoneal cavity after Ts2 or Ts6 injection.We observed
that the cells were positive for GR1, F4/80, CD3, CD4 and
CD8 markers after the Ts2 or Ts6 injection. These are the
common surface markers used to characterize neutrophils
(GR1), macrophages (F4/80þ), CD4 (CD3þ/CD4þ) and CD8
(CD3þ/CD8þ) lymphocytes (Ramalingam et al., 2003; Pillai
et al., 2009). Thus, this result reinforced the observation
that neutrophils are increased in mice injected with the
toxins and showed that the detected mononuclear cells are
mainly macrophages and lymphocytes. As expected, after
treatment with MK-886 or celecoxib, the percentage of
cells expressing surface markers to GR1þ decreased. This
could be due to the reduced number of cells recruited into
the peritoneal cavity in relation to the recruitment induced
by only Ts2 or Ts6, demonstrating that the recruitment of
these cells is at least partially dependent on LTs and PGs.
Moreover, our results revealed that neutrophils are the ﬁrst
cells recruited to the peritoneal cavity after the Ts2 or Ts6
injection. These cells together with resident cells charac-
terize the inﬂammatory response by releasing inﬂamma-
tory mediators, such as cytokines, LTB4 and PGE2, and
increasing the total protein amounts. Concurrently, the
same cells release anti-inﬂammatory cytokines, such as IL-
10 and IL-4, to re-establish the homeostasis. However, the
release of large amounts of inﬂammatory mediators over-
comes the anti-inﬂammatory mediators. Subsequently,
macrophages, CD4 and CD8 lymphocytes are recruited to
re-establish the basal homeostatic state, in a mechanism
partially dependent on PGs and LTs.
In conclusion, our data demonstrated that both Ts2 and
Ts6 induced inﬂammatory response by mechanism
dependent on lipid mediators and cytokines production.
Moreover, the data suggested that Ts2 have a regulatory
role in the inﬂammatory response, because it stimulated IL-
10 production. Ts6 showed exclusive pro-inﬂammatory
activity. Our results emphasize the importance of studies
that aim to better understand the role of isolated toxins in
envenomation. The mechanisms and the underlying
signaling pathways, as well as the novel approaches for
alternative treatments, might be useful in diminishing the
lesions caused by T. serrulatus venom and will be the focus
of our next work.
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